RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)
$3.15 -0.05 (-1.5625%)
Analysed RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) News Sources
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
20-04-2026
yahoo.com
International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026
23-04-2026
yahoo.com
Radiopharm Theranostics ADR (RADX): Inside the Clinical Programs
28-04-2026
yahoo.com
Radiopharm Theranostics Highlights Phase 1 Pipeline, Eyes June RAD 101 Data at DB Conference
29-04-2026
marketbeat.com
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
29-04-2026
yahoo.com
RADX: Fiscal 3Q:26 Cash Flow Report
12-05-2026
yahoo.com
Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
22-07-2026
yahoo.com
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
22-07-2026
yahoo.com
Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
24-07-2026
yahoo.com
Radiopharm Theranostics Reports Business Update
31-07-2026
yahoo.com
What is the current price of RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)?
The current price of RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) is $3.15.
RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) absolute price change since previous trading day?
The absolute price change of RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) since the previous trading day is $-0.05.
RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) percentage price change since previous trading day?
The percentage price change of RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) since the previous trading day is -1.5625%.
What is the most recent average sentiment score for RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)?
The most recent average sentiment score for RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)?
The most recent sentiment for RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ) is .
SEC-8K** Filing Available For RADIOPHARM THERANOSTICS LTD (RADX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.